1BYJ
GENTAMICIN C1A A-SITE COMPLEX
Summary for 1BYJ
| Entry DOI | 10.2210/pdb1byj/pdb |
| Descriptor | RNA (16S RNA), 2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose, 3,5-DIAMINO-CYCLOHEXANOL, ... (4 entities in total) |
| Functional Keywords | complex (aminoglycoside-ribosomal rna), rna |
| Total number of polymer chains | 1 |
| Total formula weight | 9109.76 |
| Authors | Yoshizawa, S.,Fourmy, D.,Puglisi, J.D. (deposition date: 1998-10-16, release date: 1999-10-29, Last modification date: 2023-12-27) |
| Primary citation | Yoshizawa, S.,Fourmy, D.,Puglisi, J.D. Structural origins of gentamicin antibiotic action. EMBO J., 17:6437-6448, 1998 Cited by PubMed Abstract: Aminoglycoside antibiotics that bind to the ribosomal A site cause misreading of the genetic code and inhibit translocation. The clinically important aminoglycoside, gentamicin C, is a mixture of three components. Binding of each gentamicin component to the ribosome and to a model RNA oligonucleotide was studied biochemically and the structure of the RNA complexed to gentamicin C1a was solved using magnetic resonance nuclear spectroscopy. Gentamicin C1a binds in the major groove of the RNA. Rings I and II of gentamicin direct specific RNA-drug interactions. Ring III of gentamicin, which distinguishes this subclass of aminoglycosides, also directs specific RNA interactions with conserved base pairs. The structure leads to a general model for specific ribosome recognition by aminoglycoside antibiotics and a possible mechanism for translational inhibition and miscoding. This study provides a structural rationale for chemical synthesis of novel aminoglycosides. PubMed: 9822590DOI: 10.1093/emboj/17.22.6437 PDB entries with the same primary citation |
| Experimental method | SOLUTION NMR |
Structure validation
Download full validation report
